Citation Impact
Citing Papers
Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment
2013 Standout
Hirsutism and oligomenorrhea are appropriate screening criteria for polycystic ovary syndrome in adolescents
2015
Excessive androgen exposure in female-to-male transsexual persons of reproductive age induces hyperplasia of the ovarian cortex and stroma but not polycystic ovary morphology
2012
Testosterone-induced downregulation of anti-Müllerian hormone expression in granulosa cells from small bovine follicles
2009
Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
2010 Standout
Recommendations from the international evidence‐based guideline for the assessment and management of polycystic ovary syndrome
2018 Standout
The effects of oxidative stress on female reproduction: a review
2012 Standout
Longitudinal assessment of antimüllerian hormone during pregnancy—relationship with maternal adiposity, insulin, and adiponectin
2009
Anti-Müllerian hormone (AMH): Regulator and marker of ovarian function
2010
Abdominal adiposity and the polycystic ovary syndrome
2007
High reproducibility of serum anti-Müllerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status
2005
d-Galactose-induced accelerated aging model: an overview
2019 Standout
Anti-Müllerian hormone and polycystic ovary syndrome: a mountain too high?
2010
Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society
2011
Serum anti-Mullerian hormone levels are negatively related to Follicular Output RaTe (FORT) in normo-cycling women undergoing controlled ovarian hyperstimulation
2010
Comparison of serum anti-Müllerian hormone levels in normal weight and overweight–obese adolescent patients with polycystic ovary syndrome
2014
Changes in anti-Mullerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility
2004
Anti-Müllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome
2007
The Complex Relationship between Hypothalamic Amenorrhea and Polycystic Ovary Syndrome
2008
Diagnosis of Polycystic Ovarian Syndrome: The Rotterdam Criteria Are Premature
2006
Animal models of polycystic ovary syndrome: a focused review of rodent models in relationship to clinical phenotypes and cardiometabolic risk
2012
Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?
2011
Evaluation of serum antimullerian hormone and inhibin B concentrations in the differential diagnosis of secondary oligoamenorrhea
2011
A 27-Year-Old Woman With a Diagnosis of Polycystic Ovary Syndrome
2007
Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?
2012
A Functional Anti-Müllerian Hormone Gene Polymorphism Is Associated with Follicle Number and Androgen Levels in Polycystic Ovary Syndrome Patients
2008
Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS)
2010
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
2018 Standout
Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism
2005
Normal serum anti-Müllerian hormone levels in the general female population and the relationship with reproductive history
2012
Diagnosis and treatment of polycystic ovarian syndrome in adolescents
2012
Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries
2011
Characterizing Discrete Subsets of Polycystic Ovary Syndrome as Defined by the Rotterdam Criteria: The Impact of Weight on Phenotype and Metabolic Features
2006
The Thrombospondins
2011 Standout
Granulosa Cell Production of Anti-Müllerian Hormone Is Increased in Polycystic Ovaries
2006
The Role of Insulin-Sensitizing Agents in the Treatment of Polycystic Ovary Syndrome
2009
Pathophysiology of Polycystic Ovary Syndrome: The Role of Hyperandrogenism
2012
Clinical uses of anti-Müllerian hormone assays: pitfalls and promises
2008
The physiology and clinical utility of anti-Müllerian hormone in women
2014 Standout
Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome
2004
Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome
2008
Defining ConstantVersusVariable Phenotypic Features of Women with Polycystic Ovary Syndrome Using Different Ethnic Groups and Populations
2006
Polycystic Ovaries Are Common in Women with Hyperandrogenic Chronic Anovulation but Do Not Predict Metabolic or Reproductive Phenotype
2005
Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts
2009
PCOS in adolescents
2009
Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume
2013
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Polycystic ovarian syndrome during puberty and adolescence
2013
Anti-Müllerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels
2008
Antimüllerian hormone levels decrease in women using combined contraception independently of administration route
2012
Is polycystic ovary syndrome an exception for reproductive aging?
2010
Physiological role and clinical utility of inositols in polycystic ovary syndrome
2016
The degree of cycle irregularity correlates with the grade of endocrine and metabolic disorders in PCOS patients
2010
PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO‐II anovulation and association with metabolic factors
2006
Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti-Mullerian hormone
2011
Polycystic ovary syndrome and its developmental origins
2007
Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization
2008
Serum Anti-Müllerian hormone (AMH) levels are differentially modulated by both serum gonadotropins and not only by serum Follicle Stimulating Hormone (FSH) levels
2011
Müllerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture
2007
Long-term follow-up of patients with polycystic ovary syndrome: reproductive outcome and ovarian reserve
2009
Measuring anti-Müllerian hormone for the assessment of ovarian reserve: When and for whom is it indicated?
2011
Fertility and infertility: Definition and epidemiology
2018 Standout
High serum dehydroepiandrosterone sulfate is associated with phenotypic acne and a reduced risk of abdominal obesity in women with polycystic ovary syndrome
2010
Oligoanovulation with Polycystic Ovaries But Not Overt Hyperandrogenism
2006
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
2008 Standout
Is foetal hyperexposure to androgens a cause of PCOS?
2017
Effect of body mass index on clinical manifestations in patients with polycystic ovary syndrome
2009
Acne vulgaris
2011 Standout
The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase–deficient nonclassic adrenal hyperplasia
2009
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
2011
Reproductive endocrinology of adolescent polycystic ovary syndrome
2009
Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique—a prospective, randomized, double-blind study
2006
Ultrasound assessment of the polycystic ovary: international consensus definitions
2003
Association of anti-mullerian hormone levels with obesity in late reproductive-age women
2006
The Role of Ovarian Volume As a Diagnostic Criterion for Chinese Adolescents with Polycystic Ovary Syndrome
2008
Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?
2007
The role of serum anti-Müllerian hormone (AMH) in the hormonal diagnosis of polycystic ovary syndrome
2013
Polycystic Ovary Syndrome and Oocyte Developmental Competence
2008
Concentrations of AMH and inhibin-B in relation to follicular diameter in normal human small antral follicles
2010
Executive summary of the Stages of Reproductive Aging Workshop + 10
2012 Standout
Polycystic ovary syndrome (PCOS)-like phenotypes in the d-galactose-induced aging mouse model
2012
Polycystic Ovary Syndrome
2005 Standout
Anti-Müllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results
2009
Adolescent Anovulation: Maturational Mechanisms and Implications
2013
Elevated serum anti-Müllerian hormone in adolescents with polycystic ovary syndrome: relationship to ultrasound features
2012
Anti-Müllerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells
2011
The Pregnancy in Polycystic Ovary Syndrome Study: baseline characteristics of the randomized cohort including racial effects
2006
Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS
2007
The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance
2016
Clinical spectrum of premature pubarche: Links to metabolic syndrome and ovarian hyperandrogenism
2008
Does AMH Reflect Follicle Number Similarly in Women with and without PCOS?
2016
Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth
2005
Polycystic ovary syndrome
1997
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
2011 Standout
Reconciling the Definitions of Polycystic Ovary Syndrome: The Ovarian Follicle Number and Serum Anti-Müllerian Hormone Concentrations Aggregate with the Markers of Hyperandrogenism
2010
Lifecycle of Polycystic Ovary Syndrome (PCOS): From In Utero to Menopause
2013
Thrombospondin‐1 inhibits VEGF levels in the ovary directly by binding and internalization via the low density lipoprotein receptor‐related protein‐1 (LRP‐1)
2006
Anti-Mullerian hormone (AMH): what do we still need to know?
2009
Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome?
2012
The phenotype of polycystic ovary syndrome ameliorates with aging
2011
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)
2009
Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome
2005
Loss of LH-induced down-regulation of anti-Mullerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome
2013
Polycystic ovary syndrome
2016 Standout
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria
2011 Standout
Antimüllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries
2012
Can Anti-Müllerian Hormone Predict the Diagnosis of Polycystic Ovary Syndrome? A Systematic Review and Meta-Analysis of Extracted Data
2013
Diagnostic criteria for PCOS: Is there a need for a rethink?
2016
Low concentration of circulating antimüllerian hormone is not predictive of reduced fecundability in young healthy women: a prospective cohort study
2012
Abnormal glucose tolerance and insulin resistance in polycystic ovary syndrome amongst the Taiwanese population- not correlated with insulin receptor substrate-1 Gly972Arg/Ala513Pro polymorphism
2006
Improvement of hyperandrogenism and hyperinsulinemia during pregnancy in women with polycystic ovary syndrome: possible effect in the ovarian follicular mass of their daughters
2011
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
2015 Standout
Anti-Mullerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome
2009
Anti-Müllerian hormone and ovarian dysfunction
2008
The diagnosis of polycystic ovary syndrome in adolescents
2010
Estrogenic ovulatory dysfunction or functional female hyperandrogenism: an argument to discard the term polycystic ovary syndrome
2006
The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: A pilot study
2005
Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes
2010
A single test of antimüllerian hormone in late reproductive-aged women is a good predictor of menopause
2009
Effect of Obesity on Parameters of Ovarian Reserve in Premenopausal Women
2010
High prevalence of polycystic ovary syndrome in women with mild hirsutism and no other significant clinical symptoms
2009
The Polycystic Ovary Post-Rotterdam: A Common, Age-Dependent Finding in Ovulatory Women without Metabolic Significance
2010
Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma?
2006
PCOS Forum: research in polycystic ovary syndrome today and tomorrow
2010
Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society
2013
The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria
2009 Standout
Anti-Mullerian hormone: a new marker for ovarian function
2005
Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty.
1976 Standout
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
2006 Standout
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
2012
Anti-MüLlerian Hormone as a Marker of Ovarian Reserve: An Update
2008
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Fibrillins in Adult Human Ovary and Polycystic Ovary Syndrome: Is Fibrillin-3 Affected in PCOS?
2010
American Association Of Clinical Endocrinologists, American College Of Endocrinology, And Androgen Excess And Pcos Society Disease State Clinical Review: Guide To The Best Practices In The Evaluation And Treatment Of Polycystic Ovary Syndrome - Part 2
2015
Polycystic Ovary-Like Abnormalities (PCO-L) in Women with Functional Hypothalamic Amenorrhea
2012
Health Consequences of Obesity in Youth: Childhood Predictors of Adult Disease
1998 Standout
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Ovarian imaging by magnetic resonance in adolescent girls with polycystic ovary syndrome and age‐matched controls
2013
Role of Oxidative Stress in Polycystic Ovary Syndrome
2010
Variations in the Pattern of Pubertal Changes in Boys
1970 Standout
Polycystic Ovarian Morphology in Normal Women Does Not Predict the Development of Polycystic Ovary Syndrome
2006
Reproductive and Lifestyle Determinants of Anti-Müllerian Hormone in a Large Population-based Study
2013
Serum Anti-Mullerian Hormone Concentrations Are Elevated in Oligomenorrheic Girls without Evidence of Hyperandrogenism
2010
Anti-Mullerian Hormone Protein Expression Is Reduced during the Initial Stages of Follicle Development in Human Polycystic Ovaries
2005
Hormonal Profile in Women with Polycystic Ovarian Syndrome with or without Type 1 Diabetes Mellitus
2007
Increased Oocyte Degeneration and Follicular Atresia during the Estrous Cycle in Anti-Mullerian Hormone Null Mice
2007
Anti-Mullerian Hormone Levels in Peripubertal Daughters of Women with Polycystic Ovary Syndrome
2007
Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome
2015
A rational approach to the diagnosis of polycystic ovarian syndrome during adolescence
2011
Characterization of Functionally Typical and Atypical Types of Polycystic Ovary Syndrome
2009
The Metabolic Syndrome
2008 Standout
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline
2017 Standout
Anti-Mullerian Hormone Serum Concentrations in Normoovulatory and Anovulatory Women of Reproductive Age
2004
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Estradiol and Regulation of Anti-Mullerian Hormone, Inhibin-A, and Inhibin-B Secretion: Analysis of Small Antral and Preovulatory Human Follicles’ Fluid
2006
Changes in Serum Anti-Mullerian Hormone Level during Low-Dose Recombinant Follicular-Stimulating Hormone Therapy for Anovulation in Polycystic Ovary Syndrome
2007
Physiological Aspects of Female Fertility: Role of the Environment, Modern Lifestyle, and Genetics
2016
The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited
2016
Anti-Müllerian hormone and anti-Müllerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women
2007
Criteria for Polycystic Ovarian Morphology in Polycystic Ovary Syndrome as a Function of Age
2009
Anti-Mullerian Hormone, Its Receptor, FSH Receptor, and Androgen Receptor Genes Are Overexpressed by Granulosa Cells from Stimulated Follicles in Women with Polycystic Ovary Syndrome
2008
Works of S. Jonard being referenced
Revisiting the ovarian volume as a diagnostic criterion for polycystic ovaries
2005
The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest
2004
The ovarian markers of the FSH insufficiency in functional hypothalamic amenorrhoea
2004
Serum Anti-Müllerian Hormone as a Surrogate for Antral Follicle Count for Definition of the Polycystic Ovary Syndrome
2006
Ultrasound examination of polycystic ovaries: is it worth counting the follicles?
2003
Elevated Serum Level of Anti-Mullerian Hormone in Patients with Polycystic Ovary Syndrome: Relationship to the Ovarian Follicle Excess and to the Follicular Arrest
2003
Serum Anti-M??llerian Hormone as a Surrogate for Antral Follicle Count for Definition of the Polycystic Ovary Syndrome
2006